Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 4Oropharyngeal Neoplasms 3Laryngeal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Mouth Neoplasms 2Mesothelioma 2Hypopharyngeal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Astrocytoma 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Extensive Stage Small Cell Lung Carcinoma 1Carcinoma, Squamous Cell 1

Interventions

Specimen Handling 7Magnetic Resonance Spectroscopy 7Platinum 4Cisplatin 41,2-diaminocyclohexaneplatinum II citrate 4Radiotherapy, Intensity-Modulated 3Cetuximab 3Biopsy 3(225)Ac-DOTA-c(RGDyK) 3pembrolizumab 2cemiplimab 2Radiotherapy 2Radiation 2Immunoglobulin G 2Disulfides 2Carboplatin 2ipatasertib 1durvalumab 1cabozantinib 1atezolizumab 1Transurethral Resection of Bladder 1Taxes 1Radiosurgery 1Paclitaxel 1Nivolumab 1Docetaxel 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT03258554 2026-06-02

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 2/3 Completed
196 enrolled 31 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00593840 2026-05-19

Phase II Trial Evaluating Elimination of Radiation Therapy

Washington University School of Medicine

Phase 2 Active not recruiting
74 enrolled 10 charts
Head & Neck

Laryngeal Neoplasms

NCT02734537 2026-05-15

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Eastern Cooperative Oncology Group

Phase 2 Recruiting
189 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡